{"database": "lobbying", "table": "lobbying_activities", "rows": [[1621749, "cc3335a2-fbe7-4b1b-9120-2da59a8b9c65", "Q4", "WILLIAMS AND JENSEN, PLLC", 41454, "UNITED COMPOUNDING MANAGEMENT, LLC", 2014, "fourth_quarter", "PHA", "The compounded drug benefit under the TRICARE program", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-01-15T11:19:41.613000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1621749"], "units": {}, "query_ms": 0.34905492793768644, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}